Health
Black adults take GLP-1 drugs at nearly twice the white rate. The FDA just added a vision-loss warning
In FDA's analysis of trials, 6.4 in 100,000 users a year had the eye condition, against 3.8 for comparison groups
Saturday, November 21, 2026News that matters to Black communities
Topic
In FDA's analysis of trials, 6.4 in 100,000 users a year had the eye condition, against 3.8 for comparison groups
About two in three Americans with chronic hepatitis B do not know they are infected, the CDC says, and the drug is only for people already in treatment
Get the latest news, free. We'll let you know when a big story breaks. A few a day at most.